Skip to main content

Table 4 Agreement between CLART and LA with respect to single and multiple infections in 401 women with abnormal cytology

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

LA CLART Total
Single infection Multiple infection No HPV genotypea
Single infection 89 19 13 121 (30%)
Multiple infection 40 216 3 259 (65%)
No HPV genotype a 1 0 20 21 (5%)
Total 130 (32%) 235 (59%) 36 (9%) 401 (100%)
  1. aOr genotypes not detectable by both CLART and LA (CLART: 43, 44, 85, 89; LA: 55, 64, 67, 69, IS39, CP6108).